Behavioral Evaluation of rotenone model of Parkinson’s disease in male Wistar rats | ||||
Sohag Medical Journal | ||||
Article 2, Volume 24, Issue 2, April 2020, Page 8-14 PDF (224.75 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/smj.2020.21596.1089 | ||||
View on SCiNiTO | ||||
Authors | ||||
dina monir hegab 1; Omyma Galal Ahmed2; Motamed Mahmoud3; Amany Abderahman Abdelhamid4 | ||||
1Medical Physiology department, Sohag Faculty of Medicine, Sohag university | ||||
2Department of physiology, Faculty of medicine, Assuit University, Assuit, Egypt | ||||
3Department of Animal Behavior and Husbandry, Faculty of Veterinary Medicine, Sohag, University, Sohag, Egypt | ||||
4physiology department, faculty of medicine, Sohag university | ||||
Abstract | ||||
Introduction: Parkinson’s disease (PD) is a prevalent neurodegenerative disorder in elderly people. The condition is associated with damage to the dopaminergic neurons in the substantia nigra pars compacta, a great decrement of dopamine neurotransmitter in the striatum, and a deficiency of tyrosine hydroxylase; the rate-determining enzyme during dopamine formation. In rats, rotenone has been administered to induce a syndrome that mimics the behavioral and pathophysiological finding of Parkinson's disease. Aim of the work: To evaluate the behavioral aspects of PD in rotenone-treated Wistar rats. Materials and Methods: Rotenone at 2 mg/kg was injected subcutaneously to male adult Wistar rats in the rotenone-treated group once a day for 4 weeks for induction of PD. Open Field test, object recognition test, Rota-rod test, footprint test and forced swim test were performed at the end of induction. Tyrosine hydroxylase levels in the brain were measured. Results: Our data showed deteriorated behavioral aspects after rotenone treatment, with a decrease in exploration and locomotion, impaired motor coordination, asymmetrical impaired gait, increased depressive-like behaviors, reduction in short-term memory and reduction in tyrosine hydroxylase levels. Conclusion: in this study, rotenone subcutaneously at a dose of 2 mg/kg daily for 4 weeks, in adult male Wistar rats, caused the appearance of the motor and the non-motor features of PD with a marked drop-off tyrosine hydroxylase levels in the striatum. | ||||
Keywords | ||||
Rotenone; Parkinson’s disease; Wistar rats | ||||
Supplementary Files
|
||||
Statistics Article View: 605 PDF Download: 1,210 |
||||